MAPT and Alzheimer disease: Taken together, our results showed that the GP extract was able to lower, in iNs with an APP mutation, the accumulation of extracellular Aβ peptides and the phosphorylation of Tau protein at Ser214/Ser396, which are the two main pathological markers of AD.